Member Info for gixer

"nose in the trough" wellsite?

Personally I can't think of anyone more suited to mentoring a long term project in India. As for who is paying for his time. We don't yet know who is funding the project. Provexis? Chettinad Academy? or a third party???

Https://www-newsm-cn.translate.goog/shzx/202311/403607.html?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp

https://science-china-com-cn.translate.goog/2023-11/02/content_42575936.htm?_x_tr_sch=http&_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp

This Company popped up in a search the other day, Primovis Health AG Switzerland.

One of their "Market Ready Solutions" is a "Vegan Omega-3, Fruitflow 500 mg soft capsules" and is run by Thomas Stricker who worked for DSM for over 13 years.

Check out whats on the guys desk at the bottom of the page.

https://www.primovis.com/services/market-ready-solutions

Should also have copied this bit.

"Project for the purpose of assessing the cardio protective effect of Fruit flow on Doxorubicin-induced cardiotoxicity”

"Advertisement for Research/Project Assistant ‘Chettinad Academy of Research and Education

(India) and Provexis, UK collaborative Project"

https://care.edu.in/wp-content/uploads/2023/10/SP_Research_Assistant_Advt.pdf

Snippet

Indena DSM partnership (includes gut health)

Hopefully, as Indena manufacture Fruitflow, we might see something from this partnership but who knows.

https://www.indena.com/2023/10/25/indena-partners-with-dsm-firmenich-to-develop-effective-market-ready-solutions/

https://www.indena.com/press-release/indena-dsm-firmenich-pioneer-a-new-age-of-nature-through-selected-market-inspired-botanical-solutions-for-human-health/

https://www.youtube.com/watch?v=_n6JiB6hFkM

https://www.dsm.com/human-nutrition/en/talking-nutrition/press-releases/2023-10-24-indena-and-dsm-firmenich-pioneer-a-new-age-of-nature-through-selected-market.html

Simply put, because I believe I will get a good return on my investment.

All else aside, By-Health has invested a substantial amount of cash (“‘tens of millions of funds’ (RMB)”) and effort into getting a Fruitflow health claim approved in China and I have no doubt that once approved they will also be looking to get a return.

Sales from China alone should see us well into profit and who knows what else By-Health might be thinking about? 🤔

As always DYOR, WTFDIK etc.

Https://www-coozhi-com.translate.goog/jiankangyangsheng/yiliaojiankang/211979.html?_x_tr_sch=http&_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp

And this one

https://money-123-com-cn.translate.goog/show/b987996.html?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp

Love your Heart with Dr Hilary.

https://www.healthspan.co.uk/advice/heart-health/

If Provexis has already purchased €550k of stock then that would leave around the same amount at DSM.

"The Company and DSM have been in further negotiations around the inventory transfer throughout the course of 2023, and the parties expect to be able to conclude these further negotiations in the coming months. The amount of stock which the Company will finally elect to purchase from DSM remains uncertain, and it will ultimately depend on (i) the best before dates of this inventory, which remain favourable / long dated in light of recent production runs of new Fruitflow material, (ii) recent stability data which suggests that the best before dates could be further extended, (iii) estimated customer demand in 2023/24 and beyond, (iv) the comparative costs and timing of a potential production run for a new batch of material and (v) the Company's financial resources at that time."

Thing is, If DSM was carrying in excess of €1m of stock surly they thought they would be able to sell it.

Just to clarify, when I say new stock I mean from the manufacturer and not the remaining stock that DSM holds.

Since the year end we should have purchased DSM stock of around £160k as we were contracted to do so.

" The Company has contractually committed to purchase more than €550k of Fruitflow inventory from DSM thus far, of which €348k was delivered and paid for in full in the quarter ended 31 March 2023. The remainder of the inventory which the Company has contractually committed to purchase from DSM is expected to be delivered and paid for in April 2023."

"At 31 March 2023 the Group had cash balances of £379,121"

"Sales in excess of £280k have been made post year end, confirmed sales orders in excess of £155k are currently being processed and the Company is dealing with numerous sales enquiries from existing and new customers"

My guess would be that IF is not looking to raise funds until we need a new stock of FF.

BWTFDIK :)

Looks like the relaunch is close.

https://www.facebook.com/ORIRIhealth

Got a few bases covered now.

Preventing hair loss and hair growth

Treatment of cerebral ischemia-reperfusion injury

Product with the effects of brightening skin

Function of improving memory

Reducing blood fat

Lowering of blood pressure

and more

https://patents.google.com/?q=(%22water-soluble+tomato%22)&assignee=%E6%B1%A4%E8%87%A3%E5%80%8D%E5%81%A5%E8%82%A1%E4%BB%BD%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8&sort=new

Along with all the studies and the health function application for platelet aggregation you can't doubt By-Healths commitment.

Some did though.

"Application of water-soluble tomato concentrate in preparation of hair loss reducing and hair growing products"

https://patents.google.com/patent/CN116803404A/en

Another route to revenue.

Because the alliance agreement came to an end.

They might not have been given another option. But we have no idea what negotiations took place to come to the new agreement.

As for revenue.... I think this makes it clearer.

"Sales of the Fruitflow II SD ingredient in excess of £280k have been made in the six months after the Company's 31 March 2023 year end, confirmed sales orders in excess of £155k are currently being processed and the Company is dealing with numerous sales enquiries from existing and new customers for further direct sales of Fruitflow II SD in 2023 and beyond."

As Fruitflow is manufactured in the EU and shipped to the UK there should be no tariff when shipping back to the EU but that seems to be a bit of a grey area in some instances.

Link from results

https://www.bbc.co.uk/news/55648201

"The boss of M&S was using Percy Pigs as an example of a situation in which it was not yet clear whether a tariff needed to be paid.

The sweets are manufactured and packaged in Germany and then shipped to the UK - no tariffs are payable because of the trade deal.

They are then taken from the M&S warehouses and exported to stores in the Republic of Ireland, which is part of the EU.

Now, this is the complicated bit. Because they have left the EU and not been processed enough to count as being made in the UK, it may be that a tariff needs to be paid to get them back into the EU, despite them having been made in the EU in the first place.

If they had been unpacked and put on a cupcake, for example, there would be no tariff because they would have been transformed, but just storing them in the UK is not enough.

It's hard to see why this situation has emerged because it is not obviously in the interests of either the UK or the EU.

Easy answer is to warehouse FF in EU then no tariffs within EU

£280k for first six months with another £155k in the pipeline. Its only September, we have another 6 months of the financial year to go. Think you are being a bit mean at £509k :)

Ah ok. I wonder how the patent application is doing for that one. DSM has preferential access to the use this patent but i wonder how binding this partnership is remembering that it was based on DSM's study?